Ecopipam Treatment of Tourette's

Protocol ID

PSY301, 10-02-226-03

Protocol Description

This clinical research study is designed to investigate the use of a new drug, ecopipam, in the treatment of Tourette's Disorder.

Eligibility Criteria

Adults 18+ with a diagnosis of Tourette's Disorder

Primary Investigator(s)

  • Cathy L. Budman, MD

Contact Information

Christina Lipinski
516-562-3224
clipinski@nshs.edu

Last Update

October 11, 2011
  • Bookmark this Page
  • Toggle Text Size
  • Print this Page
Search Mental Health:
top